Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CLSK -8% (to delay 10-K filing), ZS -6.9%, TMDX -6.3% (narrows guidance; names new CFO), MCHP -1.4%, HON -1.4% (guidance; strategic agreement with Bombardier), BNS -1.4%, CR -0.5% (selling Engineered Materials business; revises guidance)
Other news:
- INDI -15.5% ($175 mln convertible notes offering)
- X -7.2% (President-elect Trump repeats that he will seek to block Nippon Steel's bid for US Steel)
- ELTX -5% (Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment)
- AS -4.3% (stock offering)
- RCAT -3.9% (leadership changes)
- BILL -3.5% ($1.0 bln convertible senior notes)
- MARA -3.4% (prices offering of $850 million of 0.00% convertible senior notes due 2031)
- RVMD -3% ($600 mln stock offering)
- ROIV -2.5% (Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab)
- RM -2.1% ($30 mln repurchase plan and 2025 growth expectations)
- CNTX -1.9% ($75 mln common stock offering)
- FLR -1.6% (CFO to retire; names new CFO)
- MESO -1.5% (reports Revascor improves survival and reduces major morbidity in high-risk Ischemic Heart Failure patients with inflammation)
- SAIA -1.4% (Q4 operating data)
- IPAR -1.2% (to develop off-white brand in fragrance)